NCT04500210

Brief Summary

The aim of this study is to test if an extract of Turmeric can alleviate symptoms of osteoarthritis in volunteers with osteoarthritis of the hip and or knee.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2020

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2020

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 5, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2020

Completed
Last Updated

October 25, 2021

Status Verified

July 1, 2020

Enrollment Period

8 months

First QC Date

January 3, 2020

Last Update Submit

October 22, 2021

Conditions

Keywords

Arthralgia, stiffness of joints, quality of life

Outcome Measures

Primary Outcomes (6)

  • Pain

    Difference in WOMAC pain on a 100 mm VAS scale (high levels worse)

    3 month

  • Pain

    Difference in WOMAC pain on a 100 mm VAS scale (high levels worse)

    6 month

  • ADL (Activity of daily living)

    Difference in WOMAC ADL on a 100 mm VAS scale (high levels worse)

    3 month

  • ADL (Activity of daily living)

    Difference in WOMAC ADL on a 100 mm VAS scale (high levels worse)

    6 month

  • Rescue medication

    Consumption of rescue medication from diaries (mg)

    3 month

  • Rescue medication

    Consumption of rescue medication from diaries (mg)

    6 month

Secondary Outcomes (4)

  • Stiffness of joints

    3 month

  • Stiffness of joints

    6 month

  • The volunteer evaluation of Global Disease Severity (PGAD)

    3 month

  • The volunteer evaluation of Global Disease Severity (PGAD)

    6 month

Other Outcomes (2)

  • SF-12 (Quality of life)

    3 month

  • SF-12 (quality of life)

    6 month

Study Arms (2)

Placebo

PLACEBO COMPARATOR

one capsule daily

Dietary Supplement: Placebo

Turmeric extract

ACTIVE COMPARATOR

one capsule daily

Dietary Supplement: Turmeric

Interventions

PlaceboDIETARY_SUPPLEMENT

Placebo in gelatin capsules

Placebo
TurmericDIETARY_SUPPLEMENT

Turmeric in gelatin capsules

Turmeric extract

Eligibility Criteria

Age40 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy Volunteers
  • years of age or more
  • Osteoarthritis of the hip and or the knee
  • Suffering from pain in the hip and or knee -

You may not qualify if:

  • If volunteers are on a waiting list for hip or knee surgery
  • If the volunteers are involved in an other clinical trial
  • If the volunteers are taking other herbal remedies, which canhav influende on # Osteoarthritis.
  • Abusers of alcohol and drugs
  • Volunteers not easy to cope with

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nutrition, Exercise and Sports

Copenhagen, 1958 Frb. C, Denmark

Location

MeSH Terms

Conditions

Arthralgia

Interventions

Curcumin

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DiarylheptanoidsHeptanesAlkanesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, Cyclic

Study Officials

  • Kaj W Hansen, Prof, DMSCi

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Half of the volunteers are given placebo and half of the volunteers are given Turmeric extract
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
professor, MD, DMsCi

Study Record Dates

First Submitted

January 3, 2020

First Posted

August 5, 2020

Study Start

January 1, 2020

Primary Completion

September 7, 2020

Study Completion

September 7, 2020

Last Updated

October 25, 2021

Record last verified: 2020-07

Locations